This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Adam Washburn
Sr. Advisor at Eli Lilly and Company


Dr. Adam Washburn is a Sr. Advisor at Eli Lilly and Company. His group supports bioproduct analytical development for monoclonal antibodies, peptides, and novel therapeutic modalities. His recent work has included analytical method development for AAV gene therapy.

Agenda Sessions

  • Transitioning from Monoclonal Antibody Separation Science to AAV Separation Science